Clinical Trial Update: Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating blinatumomab in combination with venetoclax as maintenance therapy after allogeneic stem cell transplantation in high-risk Phila…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)
• Venetoclax (venetoclax)

Snippet

Sponsor: Zhejiang University | Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult | Phase 2 | Status: ACTIVE_NOT_RECRUITING